Genocea Biosciences (GNCA) Tops Q4 EPS by 12c; Announces Diantha Duvall as New CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Genocea Reports Fourth Quarter 2018 Results and Announces Hiring of New Chief Financial Officer
February 28, 2019 8:01 AM ESTCompany advancing lead clinical-stage neoantigen cancer vaccine candidate and expanding pipeline into adoptive cell therapy
Diantha Duvall to join as CFO, bringing broad life science financial leadership experience
Conference call today at 9:00 am ET
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:... More



